Pub Date : 2024-12-16DOI: 10.1016/j.clindermatol.2024.12.006
Madisen A Swallow, Richard Edelson, Michael Girardi
Cutaneous T cell lymphoma (CTCL) is a form of non-Hodgkin lymphoma that can involve the skin, along with lymph nodes and blood. The two most common subtypes of CTCL are mycosis fungoides and Sézary syndrome. Since the initial description of mycosis fungoides by Dr Jean-Louis Alibert in 1806, there have been significant advances in our understanding of the pathogenesis of CTCL, its diverse clinical and histologic variants, and the evolving treatment landscape. One major contributor to this story has been Dr Irwin Braverman, former vice chair of Dermatology at the Yale School of Medicine. Herein, we provide tribute to his discoveries, teaching, mentorship, and clinical care that have influenced our insights into CTCL and emerging treatments for this challenging malignancy.
{"title":"A Yale dermatology perspective on cutaneous T cell lymphoma: Historic reflection to emerging therapies.","authors":"Madisen A Swallow, Richard Edelson, Michael Girardi","doi":"10.1016/j.clindermatol.2024.12.006","DOIUrl":"10.1016/j.clindermatol.2024.12.006","url":null,"abstract":"<p><p>Cutaneous T cell lymphoma (CTCL) is a form of non-Hodgkin lymphoma that can involve the skin, along with lymph nodes and blood. The two most common subtypes of CTCL are mycosis fungoides and Sézary syndrome. Since the initial description of mycosis fungoides by Dr Jean-Louis Alibert in 1806, there have been significant advances in our understanding of the pathogenesis of CTCL, its diverse clinical and histologic variants, and the evolving treatment landscape. One major contributor to this story has been Dr Irwin Braverman, former vice chair of Dermatology at the Yale School of Medicine. Herein, we provide tribute to his discoveries, teaching, mentorship, and clinical care that have influenced our insights into CTCL and emerging treatments for this challenging malignancy.</p>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142853195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-15DOI: 10.1016/j.clindermatol.2024.12.011
Matthew D Vesely
Dr Irwin M. Braverman has advanced our understanding of cutaneous manifestations of autoimmune connective tissue diseases (AI-CTD). Before the era of molecular diagnostics, Dr Braverman's careful clinical observations and detailed descriptions of patients with AI-CTD in his textbook Skin Signs of Systemic Disease provided insights into disease characterization, progression, and evolution. Patients from Dr Braverman's career who did not fulfill criteria for a single clinical entity but rather were diagnosed with undifferentiated connective tissue disease or mixed connective tissue disease are discussed. In addition, key observations of Dr Braverman into the cutaneous manifestations of Sjögren syndrome and the systemic complications of urticarial vasculitis are highlighted.
Irwin M. Braverman 博士推动了我们对自身免疫性结缔组织疾病(AI-CTD)皮肤表现的认识。在分子诊断时代到来之前,布拉夫曼博士在他的教科书《系统性疾病的皮肤体征》中对自身免疫性结缔组织疾病患者进行了细致的临床观察和详细描述,为疾病的特征描述、进展和演变提供了真知灼见。本文讨论了布拉夫曼医生职业生涯中那些不符合单一临床实体标准,而是被诊断为未分化结缔组织病或混合性结缔组织病的患者。此外,还重点介绍了布拉夫曼博士对斯约恩综合征皮肤表现和荨麻疹性血管炎全身并发症的主要观察结果。
{"title":"Mixed and undifferentiated autoimmune connective tissue diseases.","authors":"Matthew D Vesely","doi":"10.1016/j.clindermatol.2024.12.011","DOIUrl":"10.1016/j.clindermatol.2024.12.011","url":null,"abstract":"<p><p>Dr Irwin M. Braverman has advanced our understanding of cutaneous manifestations of autoimmune connective tissue diseases (AI-CTD). Before the era of molecular diagnostics, Dr Braverman's careful clinical observations and detailed descriptions of patients with AI-CTD in his textbook Skin Signs of Systemic Disease provided insights into disease characterization, progression, and evolution. Patients from Dr Braverman's career who did not fulfill criteria for a single clinical entity but rather were diagnosed with undifferentiated connective tissue disease or mixed connective tissue disease are discussed. In addition, key observations of Dr Braverman into the cutaneous manifestations of Sjögren syndrome and the systemic complications of urticarial vasculitis are highlighted.</p>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142834332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-15DOI: 10.1016/j.clindermatol.2024.12.008
Caroline A Nelson, Jonathan S Leventhal
Although rare, life-threatening dermatoses encompass various inflammatory, infectious, vasculitic/vasculopathy, paraneoplastic, and neoplastic skin diseases. Complications include skin barrier dysfunction, secondary infection, and internal organ involvement. Skin signs may serve as a critical window into systemic disease. Life-threatening dermatoses are typically associated with "red flag" clinical signs or symptoms, which inform the dermatologist about the severity of the disease and mandate a thorough history, review of systems, physical examination, and laboratory evaluation. This contribution highlights severe cutaneous adverse reactions, infections, vasculitides and vasculopathies, and paraneoplastic eruptions. Dermatologists should recognize life-threatening dermatoses and have a framework for rapid diagnosis and management.
{"title":"Life-threatening dermatoses.","authors":"Caroline A Nelson, Jonathan S Leventhal","doi":"10.1016/j.clindermatol.2024.12.008","DOIUrl":"10.1016/j.clindermatol.2024.12.008","url":null,"abstract":"<p><p>Although rare, life-threatening dermatoses encompass various inflammatory, infectious, vasculitic/vasculopathy, paraneoplastic, and neoplastic skin diseases. Complications include skin barrier dysfunction, secondary infection, and internal organ involvement. Skin signs may serve as a critical window into systemic disease. Life-threatening dermatoses are typically associated with \"red flag\" clinical signs or symptoms, which inform the dermatologist about the severity of the disease and mandate a thorough history, review of systems, physical examination, and laboratory evaluation. This contribution highlights severe cutaneous adverse reactions, infections, vasculitides and vasculopathies, and paraneoplastic eruptions. Dermatologists should recognize life-threatening dermatoses and have a framework for rapid diagnosis and management.</p>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142834292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-14DOI: 10.1016/j.clindermatol.2024.12.015
Kalman L Watsky, Linda Friedlaender
Irwin Braverman, MD has had a lifelong interest in and appreciation of fine art and the importance of close observation as an essential skill in clinical medicine. These passions converged in his development, with Linda Friedlaender, Head of Education at the Yale Center for British Art, of a workshop for Yale medical students that brought them to the museum to examine paintings much as one would a patient with an unknown disorder. Needs to be longer.
{"title":"Irwin M. Braverman, MD, and Paintings in the Yale Center for British Art.","authors":"Kalman L Watsky, Linda Friedlaender","doi":"10.1016/j.clindermatol.2024.12.015","DOIUrl":"https://doi.org/10.1016/j.clindermatol.2024.12.015","url":null,"abstract":"<p><p>Irwin Braverman, MD has had a lifelong interest in and appreciation of fine art and the importance of close observation as an essential skill in clinical medicine. These passions converged in his development, with Linda Friedlaender, Head of Education at the Yale Center for British Art, of a workshop for Yale medical students that brought them to the museum to examine paintings much as one would a patient with an unknown disorder. Needs to be longer.</p>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142834290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-14DOI: 10.1016/j.clindermatol.2024.12.010
Suguru Imaeda, Mary M Tomayko
Dermatology faculty are responsible for the undergraduate education of all medical students, most of whom will not become dermatologists but will, nonetheless, encounter skin disease throughout their careers, and for dermatology residents' intensive, specialized graduate education. Over the past 75 years, dermatology faculty have grappled with determining what comprises the fundamental curriculum and how to teach it effectively, grumbled about time limitations, and eloquently debated the fundamental role of dermatology in general medical education. While dermatology trainee education continues to evolve, fundamentals still focus on observational skills developed through clinical and nonclinical experiences. We highlight major trends and turning points in undergraduate and graduate dermatology education that have occurred during the career of Dr. Irwin M. Braverman, many of which Dr. Braverman himself influenced, and reflect on the current state of dermatology education at our institution.
皮肤科教师负责所有医科学生的本科教育,他们中的大多数人虽然不会成为皮肤科医生,但在其职业生涯中会遇到皮肤病,同时也负责皮肤科住院医师的强化专业研究生教育。在过去的 75 年中,皮肤科教师们一直在努力确定基础课程的内容以及如何有效地进行教学,对时间限制怨声载道,并对皮肤科在普通医学教育中的基本作用进行了雄辩的辩论。虽然皮肤科受训人员的教育在不断发展,但基础课程仍侧重于通过临床和非临床经验培养观察技能。我们将重点介绍 Irwin M. Braverman 博士职业生涯中出现的本科生和研究生皮肤病学教育的主要趋势和转折点,其中许多趋势和转折点是受 Braverman 博士本人的影响而形成的,并对我院皮肤病学教育的现状进行反思。
{"title":"Medical Education in Dermatology.","authors":"Suguru Imaeda, Mary M Tomayko","doi":"10.1016/j.clindermatol.2024.12.010","DOIUrl":"https://doi.org/10.1016/j.clindermatol.2024.12.010","url":null,"abstract":"<p><p>Dermatology faculty are responsible for the undergraduate education of all medical students, most of whom will not become dermatologists but will, nonetheless, encounter skin disease throughout their careers, and for dermatology residents' intensive, specialized graduate education. Over the past 75 years, dermatology faculty have grappled with determining what comprises the fundamental curriculum and how to teach it effectively, grumbled about time limitations, and eloquently debated the fundamental role of dermatology in general medical education. While dermatology trainee education continues to evolve, fundamentals still focus on observational skills developed through clinical and nonclinical experiences. We highlight major trends and turning points in undergraduate and graduate dermatology education that have occurred during the career of Dr. Irwin M. Braverman, many of which Dr. Braverman himself influenced, and reflect on the current state of dermatology education at our institution.</p>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142834294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-13DOI: 10.1016/j.clindermatol.2024.12.007
Ian D Odell
Scleroderma is a heterogeneous disease with various clinical findings involving immune dysregulation, vasculopathy, and fibrosis. Biological and genetic studies over recent decades have elucidated molecular mechanisms of scleroderma pathogenesis. Genetic association studies have identified interferon and other immune regulatory genes as strongly linked to scleroderma risk, highlighting the immune system as a fundamental determinant of disease. Human and murine biological studies have identified growth factor signaling as a central feature linking tissue damage to the clinical phenotype. Growth factors activated in vascular endothelial cells overlap with those of other diseases having vascular abnormalities, such as hereditary hemorrhagic telangiectasia. Activated growth factor receptors in fibroblasts drive excessive collagen expression in the skin and lungs. Because growth factor signaling is overactivated in multiple malignancies, biological insights and therapeutic approaches may be translated from oncology to understand scleroderma better. Enhanced understanding of the molecular drivers of scleroderma pathogenesis has given greater insight into patient phenotypes and new therapeutic approaches, including those that target immune and growth factor signaling.
{"title":"Genetic and molecular drivers of scleroderma pathogenesis.","authors":"Ian D Odell","doi":"10.1016/j.clindermatol.2024.12.007","DOIUrl":"10.1016/j.clindermatol.2024.12.007","url":null,"abstract":"<p><p>Scleroderma is a heterogeneous disease with various clinical findings involving immune dysregulation, vasculopathy, and fibrosis. Biological and genetic studies over recent decades have elucidated molecular mechanisms of scleroderma pathogenesis. Genetic association studies have identified interferon and other immune regulatory genes as strongly linked to scleroderma risk, highlighting the immune system as a fundamental determinant of disease. Human and murine biological studies have identified growth factor signaling as a central feature linking tissue damage to the clinical phenotype. Growth factors activated in vascular endothelial cells overlap with those of other diseases having vascular abnormalities, such as hereditary hemorrhagic telangiectasia. Activated growth factor receptors in fibroblasts drive excessive collagen expression in the skin and lungs. Because growth factor signaling is overactivated in multiple malignancies, biological insights and therapeutic approaches may be translated from oncology to understand scleroderma better. Enhanced understanding of the molecular drivers of scleroderma pathogenesis has given greater insight into patient phenotypes and new therapeutic approaches, including those that target immune and growth factor signaling.</p>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142827526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-13DOI: 10.1016/j.clindermatol.2024.12.003
Leonard J Hoenig, Uwe Wollina, Gerard Tilles, Daniel Wallach, Lawrence Charles Parish
In 1822, France's Ministry of the Interior, concerned about dropping vaccination rates among the population, commissioned the French artist Constant Joseph Desbordes (1761-1828) to create an artwork that would educate the public about the benefits of the smallpox vaccine. The painting that resulted is entitled: "La Vaccine" ("The Cowpox Inoculation") and a copy of it is entitled "La Vaccine au Chateau de Liancourt" ("Performing the Vaccination against Smallpox in the Chateau of Liancourt").The highlight of the painting is its central figure, one of France's most distinguished physicians, Jean-Louis Alibert (1768-1837) performing, in dramatic fashion, the arm to arm method of smallpox vaccination that was common at that time. The painting was highly praised for bringing together, on opposite sides of the painting, persons from lower and upper socioeconomic classes, with Alibert serving as a bridge between them. The setting for the painting is a chateau and there is no evidence that a smallpox vaccination ever took place there. Thus, this painting is not a record of a specific, real-life vaccination but a celebration of vaccination itself, in an idealized artistic representation. The painting honors Alibert, a strong advocate of vaccination and demonstrates how art can impact patient education.
1822 年,法国内政部担心民众接种率下降,委托法国艺术家康斯坦-约瑟夫-德博尔德(Constant Joseph Desbordes,1761-1828 年)创作一幅艺术作品,向公众宣传天花疫苗的益处。这幅画被命名为 "La Vaccine"(《天花接种》),其副本被命名为 "La Vaccine au Chateau de Liancourt"(《在 Liancourt 城堡进行天花疫苗接种》)。这幅画的亮点在于其中心人物,法国最杰出的医生之一让-路易-阿利贝尔(1768-1837 年)以戏剧性的方式表演了当时常见的天花疫苗接种方法。这幅画备受赞誉,因为它将社会经济地位低下和地位较高的人聚集在画的两侧,而阿利伯特则是他们之间的桥梁。这幅画的背景是一座城堡,但没有证据表明那里曾经进行过天花疫苗接种。因此,这幅画并不是对现实生活中具体的疫苗接种的记录,而是以理想化的艺术表现形式对疫苗接种本身的赞美。这幅画是为了纪念阿利伯特这位疫苗接种的坚定倡导者,同时也展示了艺术对患者教育的影响。
{"title":"Constant Joseph Desbordes' painting of Jean-Louis Alibert administering the smallpox vaccine (\"La Vaccine\"): An historic vaccination or artistic imagination?","authors":"Leonard J Hoenig, Uwe Wollina, Gerard Tilles, Daniel Wallach, Lawrence Charles Parish","doi":"10.1016/j.clindermatol.2024.12.003","DOIUrl":"10.1016/j.clindermatol.2024.12.003","url":null,"abstract":"<p><p>In 1822, France's Ministry of the Interior, concerned about dropping vaccination rates among the population, commissioned the French artist Constant Joseph Desbordes (1761-1828) to create an artwork that would educate the public about the benefits of the smallpox vaccine. The painting that resulted is entitled: \"La Vaccine\" (\"The Cowpox Inoculation\") and a copy of it is entitled \"La Vaccine au Chateau de Liancourt\" (\"Performing the Vaccination against Smallpox in the Chateau of Liancourt\").The highlight of the painting is its central figure, one of France's most distinguished physicians, Jean-Louis Alibert (1768-1837) performing, in dramatic fashion, the arm to arm method of smallpox vaccination that was common at that time. The painting was highly praised for bringing together, on opposite sides of the painting, persons from lower and upper socioeconomic classes, with Alibert serving as a bridge between them. The setting for the painting is a chateau and there is no evidence that a smallpox vaccination ever took place there. Thus, this painting is not a record of a specific, real-life vaccination but a celebration of vaccination itself, in an idealized artistic representation. The painting honors Alibert, a strong advocate of vaccination and demonstrates how art can impact patient education.</p>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142827525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-09DOI: 10.1016/j.clindermatol.2024.12.001
Jahleel Perrin, Jessica Norman, Francisco Padron, Sheryl Hoyer
{"title":"Skin Cancer Rates and Patterns of Sunscreen Use in Black and Latino Communities in the U.S: A Review.","authors":"Jahleel Perrin, Jessica Norman, Francisco Padron, Sheryl Hoyer","doi":"10.1016/j.clindermatol.2024.12.001","DOIUrl":"10.1016/j.clindermatol.2024.12.001","url":null,"abstract":"","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142812249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-07DOI: 10.1016/j.clindermatol.2024.12.002
Kaushik P Venkatesh, Gabriel Brito, Vinod E Nambudiri
{"title":"Dermatology office visit out-of-pocket costs and copays: A Medicare Physician Office Visit Costs database study, 2020-2024.","authors":"Kaushik P Venkatesh, Gabriel Brito, Vinod E Nambudiri","doi":"10.1016/j.clindermatol.2024.12.002","DOIUrl":"10.1016/j.clindermatol.2024.12.002","url":null,"abstract":"","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142799511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-03DOI: 10.1016/j.clindermatol.2024.11.005
Akash Rau, Andrew Z Li, Julia Giordano, Jane M Grant-Kels, Zelma C Chiesa Fuxench
The proliferation of medical spas has led to an increase in misleading advertising practices, particularly relating to the qualifications of practitioners and the risks of cosmetic procedures. Estheticians manage many spas without having the extensive and rigorous training that board-certified dermatologists undergo. By advertising physician oversight when there is none and promoting procedures as minimally invasive, these facilities create a false sense of security for patients. Procedures such as laser therapies and injectables require specialized expertise to avoid and, if necessary, treat potentially dangerous complications. The ethics of misleading advertising in dermatology must be considered due to its impact on patient decision-making (autonomy), safety (beneficence), and confidence regarding the medical profession.
{"title":"Impersonating expertise: The ethics of misleading dermatology advertising.","authors":"Akash Rau, Andrew Z Li, Julia Giordano, Jane M Grant-Kels, Zelma C Chiesa Fuxench","doi":"10.1016/j.clindermatol.2024.11.005","DOIUrl":"10.1016/j.clindermatol.2024.11.005","url":null,"abstract":"<p><p>The proliferation of medical spas has led to an increase in misleading advertising practices, particularly relating to the qualifications of practitioners and the risks of cosmetic procedures. Estheticians manage many spas without having the extensive and rigorous training that board-certified dermatologists undergo. By advertising physician oversight when there is none and promoting procedures as minimally invasive, these facilities create a false sense of security for patients. Procedures such as laser therapies and injectables require specialized expertise to avoid and, if necessary, treat potentially dangerous complications. The ethics of misleading advertising in dermatology must be considered due to its impact on patient decision-making (autonomy), safety (beneficence), and confidence regarding the medical profession.</p>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142784346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}